FDA Inspection 1076436 — Aspire Fertility Institute McAllen
The FDA completed an inspection of Aspire Fertility Institute McAllen on Dec 17, 2018 in Mcallen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Mcallen, TX (United States)